Close
ACHEMA MIDDLE EAST 2026

Seqirus, North Carolina Gets Fill Finish Expansion of $156mn

Seqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish production plant, which began in 2018. The expanded facility,...

GARDP Helps Bugworks Assess New Antibiotics Effectiveness

The Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine the safety profile of a novel class of broad-spectrum...

GSK Unveils Its Transformation Through New Branding And Logo

The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns GSK and...

Vazkepa From Amarin Gets Recommended By NICE In The U.K

Amarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa has been approved by the National Institute for Health...

After Lupin Deal Teva Holds Another Austedo Rival To 2033

Teva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as it focuses on the...

Rejected By The FDA, NICE Endorses The Anaemia Drug Evrenzo

Despite a high-profile FDA denial, FibroGen and its collaborators have been able to expand into new markets outside of the United States with Evrenzo,...

Time Congress Acts As Drug Launch Prices Go Up 20% Annually

As many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years: drug prices are significantly...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...